First Trust Advisors LP Mersana Therapeutics, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$13.28 - $18.07 $792,616 - $1.08 Million
-59,685 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$15.31 - $26.52 $224,873 - $389,525
14,688 Added 32.64%
59,685 $966,000
Q4 2020

Feb 02, 2021
BUY
$16.84 - $27.59 $757,749 - $1.24 Million
44,997 New
44,997 $1.2 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $198M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email